The global healthcare sector is witnessing a transformative phase in vascular care, highlighted by a freshly published analysis from Metastat Insight. The comprehensive research reveals that the global peripheral vascular devices market size is valued at USD 9.4 billion in 2025 and is projected to experience robust expansion at a Compound Annual Growth Rate (CAGR) of 6.6% during the forecast period, ultimately reaching USD 15.7 billion by 2033.
Peripheral vascular devices serve as critical tools for treating peripheral arterial or coronary arterial disease. These advanced instruments are widely utilized in both peripheral endovascular and coronary procedures to restore proper blood circulation. According to the report, the extensive device ecosystem encompasses Carotid and Renal Artery Stents, Peripheral Embolic Protection Devices, Arteriotomy Closure Devices, PTA Balloon Catheters, Peripheral Vascular Stents, Peripheral Guidewires, Renal Denervation Catheters, and PV Embolization Plugs & Coils.
Key Market Dynamics Accelerating Growth
The prominent catalyst driving the global expansion is the rising incidence of peripheral artery disease (PAD) across various populations. Data documented by the National Center for Chronic Disease Prevention indicates that globally, more than 236.62 million individuals aged 25 years and older live with peripheral artery disease as of 2019. Furthermore, statistics from the American Heart Association noted that in 2018, approximately 8.5 million individuals age 40 and older suffered from PAD in the U.S., while Canadian data shows 800,000 people living with some form of the condition.
Beyond patient epidemiology, the market is receiving an immense boost from increasing regulatory approvals of novel peripheral vascular devices. Breakthrough innovations, such as Concept Medical receiving a CE Certification for Magic Touch PTA 0.035 OTW (Percutaneous Transluminal Angioplasty)-a Sirolimus drug-coated balloon (DCB) catheter designed to treat PAD and prevent re-narrowing in superficial femoral and popliteal arteries-underscore the active commercialization landscape.
While technological advancements offer lucrative industry opportunities, the market faces notable hurdles. Serious product recalls have the potential to temporarily hamper market trajectory. For example, the U.S. Food and Drug Administration (FDA) previously designated Medtronic's recall of the 6-French Sherpa NX Active Guide catheter as a Class 1 recall—the most severe category due to risks associated with outer material separation, exposed stainless-steel braid wires, and potential injury or death.
Segmentation Analysis: Stents Capture Substantial Share
The comprehensive sector assessment by Metastat Insight segments the global landscape by product type and end user:
-
By Type: The sector breaks down into Carotid and Renal Artery Stents, PTA Balloon Catheters, Vascular Stents, Peripheral Embolic Protection Devices, Arteriotomy Closure Devices, Peripheral Guidewires, Renal Denervation Catheters, and PV Embolization Plugs & Coils.
-
By End User: Key facilities delivering these interventions include Hospitals, Clinics, Ambulatory Surgical Centers, and Others.
Notably, Peripheral Vascular Stents registered a larger share in 2021, propelled by expanding commercial deployment, rising corporate partnerships, and ongoing investigational trials. Milestones such as the U.S. FDA approval of Boston Scientific’s Eluvia Drug-Eluting Vascular Stent System which leverages a sustained-release drug-polymer matrix to inhibit tissue regrowth inside stented arteries exemplify the ongoing structural shifting toward premium, targeted devices.
Geographically, North America dominated the global market arena in 2020. This stronghold stems from extensive regional R&D funding, high PAD prevalence, and swift introduction of leading-edge technology like Terumo Medical Corporation's R2P MISAGO RX Self-expanding Peripheral Stent, which accommodates transradial access routes for above-the-knee interventions.
For more deep-dive metrics, request a sample or read the complete report overview directly on the Metastat Insight portal.
About Metastat Insight:
Metastat Insight is a premier global market research firm specializing in accurate, high-impact clinical and technology sector analysis across various industrial domains, including healthcare and medical devices.